Federal Register / Vol. 69, No. 205 / Monday, October 25, 2004 / Notices 62275

nominated for consideration: (1) A letter 

of nomination that clearly states the 

name and affiliation of the nominee, the 

basis for the nomination (i.e., specific 

attributes which qualify the nominee for 

service in this capacity), and a statement 

that the nominee is willing to serve as 

a member of the Committee; (2) the 

nominator’s name, address and daytime 

telephone number, and the home and/

or work address, telephone number, and 

email address of the individual being 

nominated; and (3) a current copy of the 

nominee’s curriculum vitae. The names 

of Federal employees should not be 

nominated for consideration of 

appointment to this Committee. 

The Department makes every effort to 

ensure that the membership of HHS 

Federal advisory committees is fairly 

balanced in terms of points of view 

represented and the committee’s 

function. Every effort is made to ensure 

that a broad representation of 

geographic areas, females, ethnic and 

minority groups, and the disabled are 

given consideration for membership on 

HHS Federal advisory committees. 

Appointment to this Committee shall be 

made without discrimination on the 

basis of age, race, ethnicity, gender, 

sexual orientation, disability, and 

cultural, religious, or socioeconomic 

status. Nominations must state that the 

nominee is willing to serve as a member 

of SACHRP and appears to have no 

conflict of interest that would preclude 

membership. Potential candidates are 

required to provide detailed information 

concerning such matters as financial 

holdings, consultancies, and research 

grants or contracts to permit evaluation 

of possible sources of conflict of 

interest.

Dated: October 19, 2004. 

Bernard A. Schwetz, 

Executive Secretary, Secretary’s Advisory 

Committee on Human Research Protections, 

Director, Office for Human Research 

Protections.

[FR Doc. 04–23764 Filed 10–22–04; 8:45 am] 

BILLING CODE 4150–36–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–05AA] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–498–1210 or send 

comments to Seleda Perryman, CDC 

Assistant Reports Clearance Officer, 

1600 Clifton Road, MS–E11, Atlanta, GA 

30333 or send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

EHDI Hearing Screening and Followup Survey—New—National Center on 

Birth Defects and Developmental 

Disabilities (NCBDDD), Centers for 

Disease Control and Prevention (CDC). 

Background and brief description:

CDC, National Center on Birth Defects 

and Developmental Disabilities 

promotes the health of babies, children, 

and adults with disabilities. As part of 

the mission of CDC, the National Center 

on Birth Defects and Developmental 

Disabilities is actively involved in 

addressing hearing loss (HL) among 

newborns and infants. HL is a common 

birth defect that affects approximately 

12,000 infants each year and, when left 

undetected, can result in developmental 

delays. As awareness about infant HL 

increases, so does the demand for 

accurate information about rates of 

screening, referral, loss to follow-up, 

and incidence. This information is 

important for helping to ensure infants 

and children are receiving 

recommended screening and follow-up 

services, documenting the occurrence 

and etiology of differing degrees of HL 

among infants, and determining the 

overall impact of infant HL on future 

outcomes, such as cognitive 

development, and family dynamics. 

These data will also assist state EHDI 

programs with quality improvement 

activities and provide information that 

will be helpful in assessing the impact 

of Federal initiatives. The public will be 

able to access this information via the 

CDC–EHDI Web site http://

www.cdc.gov/ncbddd/ehdi/. 

Given the lack of a standardized and 

readily accessible source of data, CDC’s 

Early Hearing Detection and 

Intervention (EHDI) program has 

developed a survey to be used annually 

that utilizes uniform definitions to 

collect aggregate, standardized EHDI 

data from states and territories. This 

survey is based on a form developed by 

the Directors of Speech and Hearing 

Programs in State Health and Welfare 

Agencies (DSHPSHWA), which is a 

nongovernmental agency that gave 

CDC–EHDI permission to use their 

survey form. After year 2004, 

DSHPSHWA no longer plans to 

disseminate this or any other EHDIrelated data collection form. There are 

no costs to respondents other than their 

time.

ANNUALIZED BURDEN TABLE

Respondents Number of respondents 

Number of responses per 

respondent 

Average burden per response

(in hrs.) 

Total burden 

hours 

State and territory EHDI Program Coordinators .............................................. 53 1 4 212 

Total .......................................................................................................... ........................ ........................ ........................ 212 

62276 Federal Register / Vol. 69, No. 205 / Monday, October 25, 2004 / Notices 

Dated: October 18, 2004. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention.

[FR Doc. 04–23813 Filed 10–22–04; 8:45 am] 

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Iowa Ordnance Plant

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS).

ACTION: Notice.

SUMMARY: The Department of Health and 

Human Services gives notice of a 

decision to evaluate a petition to 

designate a class of employees at the 

Iowa Ordnance Plant, also known as the 

Iowa Army Ammunition Plant, in 

Burlington, Iowa to be included in the 

Special Exposure Cohort under the 

Energy Employees Occupational Illness 

Compensation Program Act of 2000. The 

initial proposed definition for the class 

being evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Iowa Ordnance Plant, 

Burlington, Iowa. 

Locations: Line 1 (which includes 

Yard C, Yard G, Yard L, Firing Site 

Area, Burning Field ‘‘B’’, and Storage 

Sites for Pits and Weapons including 

Buildings 73 and 77). 

Job Titles and/or Job Duties: All 

Technicians (Laboratory, Health 

Physics, Chemical, X-ray, etc.), 

Production Personnel (hourly and 

salaried), Engineers, Inspectors, Safety 

Personnel, Physical Security Personnel, 

and Maintenance Persons. Period of 

Employment: 1947–1974.

FOR FURTHER INFORMATION CONTACT:

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, telephone 513–533–6800 (this is 

not a toll-free number). Information 

requests can also be submitted by e-mail 

to OCAS@CDC.GOV.

Dated: October 18, 2004. 

James D. Seligman, 

Associate Director for Program Services, 

Centers for Disease Control and Prevention.

[FR Doc. 04–23814 Filed 10–22–04; 8:45 am] 

BILLING CODE 4163–19–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Public Health Service 

National Toxicology Program; Call for 

Additional Public Comments on 21 

Substances, Mixtures and Exposure 

Circumstances Proposed for Review 

for Listing or Changing the Current 

Listing in the Report on Carcinogens, 

Twelfth Edition 

Background 

The National Toxicology Program 

(NTP) initially announced its intent to 

review additional agents, substances, 

mixtures and exposure circumstances 

for possible listing or changing the 

current listing in the Report on 

Carcinogens (RoC), Twelfth Edition in a 

May 19, 2004 Federal Register notice 

(69 FR 28940 (May 19, 2004)). Based on 

some of the comments received in 

response to this notice, the NTP is 

concerned that there might have been 

confusion about the procedures that will 

be used for review of nominations to the 

12th RoC. A detailed description of the 

current review procedures, including 

the steps in the formal review process, 

is available on the Web at http://ntpserver.niehs.nih.gov (select on Report on 

Carcinogens) or can be obtained by 

contacting: Dr. C.W. Jameson, National 

Toxicology Program, Report on 

Carcinogens, 79 Alexander Drive, 

Building 4401, Room 3118, PO Box 

12233, Research Triangle Park, NC 

27709; phone: (919) 541–4096, fax: (919) 

541–0144, e-mail: 

jameson@niehs.nih.gov.

Public Comment Requested 

Because of the possibility of 

confusion over the review procedures 

for the 12th RoC nominations, 

additional comments concerning the 

nominations for listing or changing the 

current listing in the 12th RoC will be 

accepted by the NTP for a period of 30 

days from the publication date of this 

announcement in the Federal Register. 

The following table identifies the 21 

nominations the NTP may consider for 

review in 2004 or 2005, as either a new 

listing in or changing the current listing 

in the 12th RoC. These nominations are 

provided with their Chemical Abstracts 

Services (CAS) Registry numbers (where 

available) and pending review action. 

Additional nominations for the 12th 

RoC or modifications to the nominations 

in the attached table may be identified 

and would be announced in future 

Federal Register notices. The NTP 

solicits public input on these 21 

nominations and asks for relevant 

information concerning their 

carcinogenesis, as well as current 

production data, use patterns, or human 

exposure information. The NTP also 

invites interested parties to identify any 

scientific issues related to the listing of 

a specific nomination in the RoC that 

they feel should be addressed during the 

reviews. 

Individuals who submitted comments 

in response to the May 19, 2004 Federal 

Register (69 FR 28940 (May 19, 2004)) 

that initially announced the 12th RoC 

nominations need not re-submit their 

comments as they are already part of the 

public record. Individuals submitting 

new or additional public comments are 

asked to include relevant contact 

information (name, affiliation (if any), 

address, telephone, fax, and e-mail). 

Comments or questions should be 

directed to Dr. C.W. Jameson at the 

address listed above. 

Additional Nominations Encouraged 

The NTP solicits and encourages the 

broadest participation from interested 

individuals or parties in nominating 

agents, substances, or mixtures for 

review for the Twelfth and future RoCs. 

Nominations should contain a rationale 

for review. Appropriate background 

information and relevant data (e.g., 

journal articles, NTP Technical Reports, 

IARC listings, exposure surveys, release 

inventories, etc.), which support the 

review of a nomination, should be 

provided or referenced when possible. 

Contact information for the nominator 

should also be included (name, 

affiliation (if any), address, telephone, 

fax, and email). Nominations should be 

sent to Dr. Jameson’s attention at the 

address given above.

Dated: October 15, 2004. 

Samuel Wilson, 

Deputy Director, National Institute of 

Environmental Health Sciences.